Publication | Open Access
Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma
14
Citations
27
References
2022
Year
This robust six-lncRNA prognostic signature may be used as a novel and powerful prognostic biomarker for lung adenocarcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1